BioSpace News Archive

IDEX Corporation (NYSE:IEX) today completed its previously announced acquisition of Abel Pumps, L.P., and certain of its affiliates (ABEL) from Hillenbrand, Inc. (NYSE: HI).

Halberd Corporation has filed for trademark protection for the name VITA-SHIELD-MAXTM for its proprietary blend of over-the-counter nutraceuticals designed to boost the body’s immunity and generally enhance health.

LigoLab, developers of enterprise software for medical laboratories and first care facilities, today announced that its direct-to-consumer platform, TestDirectly, is now equipped with Laboratory Information System (LIS) functionality that makes it a lightweight point-of-care option for low-volume testing facilities.

PH10 may have stand-alone potential to displace current oral antidepressants in the drug treatment paradigm for depression disorders

SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced that Angelos Stergiou, MD, ScD. h.c., President and Chief Executive Officer of SELLAS, will participate in the Emerging Growth Virtual Conference hosted by M Vest LLC and Maxim Group, LLC on Wednesday, March 17, 2021

Akerna (Nasdaq: KERN) (“Akerna” or the “Company”), an enterprise software company, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), announced it has signed an agreement to acquire Viridian Sciences,

Sagimet Biosciences Inc., a clinical-stage biotechnology company focused on developing a portfolio of internally-discovered, selective fatty acid synthase (FASN) inhibitors, announced today the appointment of Eduardo Bruno Martins as Chief Medical Officer

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa , Chief Executive Officer of Relmada, will participate in a fireside chat at the Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021 at 10:40 am

Leading cancer and infectious disease experts analyze latest data and FDA approvals to create evidence-based expert consensus recommendations for both treatment and prevention of COVID-19 for people with cancer.

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the successful launch of its 2021 MIDD+ Scientific Conference, a two-day event